Global Depression Drugs Market 2015-2019

Global Depression Drugs Market 2015-2019

[email protected]

USA – CANADA – UK – CHINA – INDIA


The report discusses the following in-depth:

• Market Size and Forecast

• Market Segmentation

• Buying Criteria

• Vendor Landscape

• Business Segmentation

• Geographical Segmentation

For more information on the

Global Depression Drugs Market 2015-2019,

please mail us [email protected]


Key Trends

Technavio’s Senior Analyst says, “The global depression drugs market is driven by several factors. An increase in patient population and changes in lifestyles are major factors propelling the growth of the market. Current treatment options do not provide a cure for the illness, hence, there is a significant unmet need in the market. Therefore, drugs that can cause remission of depression in patients are expected to drive the growth of the market.”

• According to WHO, clinical depression is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. An individual with severe depression can also have suicidal thoughts and exhibit suicidal behaviors.

• Technavio's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge

and trend isavailable in our report:



http://www.technavio.com/report/global-depression-drugs-market-2015-2019?utm_source=Slideshare&utm_medium=PPT&utm_content=T1&utm_campaign=Report



Vendors

To understand the vendor landscape and for a full list of vendors view our report:


Actavis

Bristol-Myers Squibb

Eli Lilly

Actavis was established in Ireland on May 16, 2013 for facilitating the business combination between Actavis and Warner Chilcott. It has its global headquarters in Dublin, Ireland and the administrative headquarters are located in New Jersey, US.

Bristol-Myers Squibb, a global biopharmaceutical company, is engaged in the discovery, manufacturing, licensing, development, marketing, distribution, and sales of biopharmaceutical products.

Eli Lilly is a biopharmaceutical company. The company undertakes development, manufacturing, and marketing of its products. Its product portfolio consists of neuroscience products, oncology products, endocrinology products, animal health products, cardiovascular products, and other pharmaceutical products.




Market Landscape

• The global depression drugs market is expected to decline gradually during the forecast period because of the expiry of patents of branded drugs.

• This is expected to allow the entry of generic drugs into the market, leading to a fall in the market share of branded drugs.

• The side effects of currently available drugs and the use of CAM by patients are other factors expected to lead to the decline of the market during the forecast period.

• However, factors such as public health approach to mental health and a promising drug pipeline are expected to drive the market.

• The market is dominated by players such as Actavis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Pfizer.


Key Buying CriteriaGuest Bloggers

• Authenticity • Delivery • Price• Service

Support

Parameters Details

Availability Drugs used in the treatment of depression should be readily available.

Efficacy Drugs should have a high degree of efficacy.

Safety Drugs used to treat depression should have a high safety profile.

Affordability

Vendors should make drugs available at reasonable costs.

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

What Would You Like to Learn From Technavio?


Let us identify your needs.We would love to hear more!



Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.

You have the Option to Customize Reports & Access Analysts on every Report Purchase.

Purchasing this report?

For media enquiries,please drop us a mail at

[email protected]

We’ll include an hour with our analysts to discuss the report findings.

For free.

mailto:[email protected]


Access the Report


India: An Overview


About Us


Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall

Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION

https://www.facebook.com/pages/TechNavio/541097752635345

https://twitter.com/TechNavio

https://www.linkedin.com/company/technavio

https://www.youtube.com/channel/UCy4jXQNIs1a_c9W9pYxZX3g

Healthcare

Global Depression Drugs Market 2015-2019